The National Pharmaceutical Pricing Authority (NPPA) on June 04, 2024, issued the notification regarding the Computation of Retail Price on Rosuvastatin Calcium IP eq. to Rosuvastatin 10 mg + Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg.
The following has been stated namely: -
• The price computation is based on the data from October 2023
• The computation of retail price is on Each film coated tablet Containing Rosuvastatin Calcium IP eq. to Rosuvastatin 10 mg + Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg for M/s. Pure & Cure Healthcare Pvt. Ltd. (Manufacturer) & M/s Torrent Pharmaceuticals Ltd. (Marketer)
• The Total MAT is 83, 60, 74, 041
[Notification No. 19(4019)/2024/DP/NPPA/DIV.II]
